Literature DB >> 23010266

Novel histone deacetylase 8 ligands without a zinc chelating group: exploring an 'upside-down' binding pose.

Aditya Sudheer Vaidya1, Raghupathi Neelarapu, Antonett Madriaga, He Bai, Emma Mendonca, Hazem Abdelkarim, Richard B van Breemen, Sylvie Y Blond, Pavel A Petukhov.   

Abstract

A novel series of HDAC8 inhibitors without a zinc-chelating hydroxamic acid moiety is reported. Photoaffinity labeling and molecular modeling studies suggest that these ligands are likely to bind in an 'upside-down' fashion in a secondary binding site proximal to the main catalytic site. The most potent ligand in the series exhibits an IC(50) of 28 μM for HDAC8 and is found to inhibit the deacetylation of H4 but not α-tubulin in SH-SY5Y cell line.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23010266      PMCID: PMC3472134          DOI: 10.1016/j.bmcl.2012.08.104

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  34 in total

Review 1.  Rational design of non-hydroxamate histone deacetylase inhibitors.

Authors:  Takayoshi Suzuki; Naoki Miyata
Journal:  Mini Rev Med Chem       Date:  2006-05       Impact factor: 3.862

2.  Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise.

Authors:  Antonello Mai; Dante Rotili; Sergio Valente; Aleksey G Kazantsev
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

3.  Insights from comprehensive multiple receptor docking to HDAC8.

Authors:  Michael Brunsteiner; Pavel A Petukhov
Journal:  J Mol Model       Date:  2012-03-20       Impact factor: 1.810

4.  Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases.

Authors:  R A Gilissen; K J Bamforth; J F Stavenuiter; M W Coughtrie; J H Meerman
Journal:  Carcinogenesis       Date:  1994-01       Impact factor: 4.944

5.  Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Authors:  John R Somoza; Robert J Skene; Bradley A Katz; Clifford Mol; Joseph D Ho; Andy J Jennings; Christine Luong; Andrew Arvai; Joseph J Buggy; Ellen Chi; Jie Tang; Bi-Ching Sang; Erik Verner; Robert Wynands; Ellen M Leahy; Douglas R Dougan; Gyorgy Snell; Marc Navre; Mark W Knuth; Ronald V Swanson; Duncan E McRee; Leslie W Tari
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

6.  A redox-switchable alpha-cyclodextrin-based [2]rotaxane.

Authors:  Yan-Li Zhao; William R Dichtel; Ali Trabolsi; Sourav Saha; Ivan Aprahamian; J Fraser Stoddart
Journal:  J Am Chem Soc       Date:  2008-08-02       Impact factor: 15.419

Review 7.  Targeting histone deacetylases in neuroblastoma.

Authors:  O Witt; H E Deubzer; M Lodrini; T Milde; I Oehme
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  The Lossen rearrangement in biological systems. Inactivation of leukocyte elastase and alpha-chymotrypsin by (dl)-3-benzyl-N-(methanesulfonyloxy) succinimide.

Authors:  W C Groutas; P K Giri; J P Crowley; J C Castrisos; M J Brubaker
Journal:  Biochem Biophys Res Commun       Date:  1986-12-15       Impact factor: 3.575

9.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

Review 10.  Sulfation and glucuronidation as competing pathways in the metabolism of hydroxamic acids: the role of N,O-sulfonation in chemical carcinogenesis of aromatic amines.

Authors:  G J Mulder; J H Meerman
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031

View more
  2 in total

1.  Photoreactive "nanorulers" detect a novel conformation of full length HDAC3-SMRT complex in solution.

Authors:  Hazem Abdelkarim; Michael Brunsteiner; Raghupathi Neelarapu; He Bai; Antonett Madriaga; Richard B van Breemen; Sylvie Y Blond; Vadim Gaponenko; Pavel A Petukhov
Journal:  ACS Chem Biol       Date:  2013-10-02       Impact factor: 5.100

2.  Purification and enzymatic assay of class I histone deacetylase enzymes.

Authors:  Mark K Adams; Charles A S Banks; Sayem Miah; Maxime Killer; Michael P Washburn
Journal:  Methods Enzymol       Date:  2019-08-13       Impact factor: 1.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.